Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Abstract 2902: Targeting the tight junction protein claudin-1 in colorectal cancer

Sara Cherradi, Adeline Ayrolles-Torro, Nadia Vezzo-Vié, Eve Combes, Lucile Canterel-Thouennon, Fabien Gava, Valérie Lobjois, Bernard Ducommun, Celine Gongora, Maguy Del Rio

Cancer Res (2018) 78 (13_Supplement): 2902.

https://doi.org/10.1158/1538-7445.AM2018-2902

Published: 01 July 2018

View article titled, Abstract 2902: Targeting the tight junction protein claudin-1 in colorectal cancer

Journal Articles

Abstract 4023: Gap junctions contribute to anchorage-independent clustering of breast cancer cells

Fabien Gava, Lise Rigal, Odile Mondesert, Elise Pesce, Bernard Ducommun, Valérie Lobjois

Cancer Res (2018) 78 (13_Supplement): 4023.

https://doi.org/10.1158/1538-7445.AM2018-4023

Published: 01 July 2018

View article titled, Abstract 4023: Gap junctions contribute to anchorage-independent clustering of breast cancer cells

Journal Articles

Abstract 5774: Effect of extrinsic and intrinsic solid stress on tumor spheroid growth

Ludivine Guillaume, Annaick Desmaison, Bernard Ducommun, Valérie Lobjois

Cancer Res (2017) 77 (13_Supplement): 5774.

https://doi.org/10.1158/1538-7445.AM2017-5774

Published: 01 July 2017

View article titled, Abstract 5774: Effect of extrinsic and intrinsic solid stress on tumor spheroid growth

Journal Articles

Abstract 5053: Tumor cell clustering - Identification of new regulators

Valérie LOBJOIS, Bernard Ducommun

Cancer Res (2016) 76 (14_Supplement): 5053.

https://doi.org/10.1158/1538-7445.AM2016-5053

Published: 15 July 2016

View article titled, Abstract 5053: Tumor cell clustering - Identification of new regulators

Journal Articles

Abstract 327: 3D dynamics of the response to cell cycle checkpoint targeting drugs in multicellular tumour spheroids

Valérie LOBJOIS, Odile MONDESERT, Céline FRONGIA, Annaick DESMAISON, Aurélie GOMES, Martine CAZALES, Bernard Ducommun

Cancer Res (2015) 75 (15_Supplement): 327.

https://doi.org/10.1158/1538-7445.AM2015-327

Published: 01 August 2015

View article titled, Abstract 327: 3D dynamics of the response to cell cycle checkpoint targeting drugs in multicellular tumour spheroids

Journal Articles

Cell–Cell Adhesion and Cytoskeleton Tension Oppose Each Other in Regulating Tumor Cell Aggregation

Laure Saias, Aurélie Gomes, Martine Cazales, Bernard Ducommun, Valérie Lobjois

Cancer Res (2015) 75 (12): 2426–2433.

https://doi.org/10.1158/0008-5472.CAN-14-3534

Published: 14 June 2015

View article titled, Cell–Cell Adhesion and Cytoskeleton Tension Oppose Each Other in Regulating Tumor Cell Aggregation

Includes: Multimedia, Supplementary data

Journal Articles

Abstract 2025: Multicellular tumor spheroid 3D models to decipher cancer cell biology and to evaluate anticancer drugs

Bernard Ducommun, Valérie Lobjois

Cancer Res (2014) 74 (19_Supplement): 2025.

https://doi.org/10.1158/1538-7445.AM2014-2025

Published: 01 October 2014

View article titled, Abstract 2025: Multicellular tumor spheroid 3D models to decipher cancer cell biology and to evaluate anticancer drugs

Journal Articles

Abstract 560: Mechanical stress activates a mitotic checkpoint in multicellular tumor spheroids.

Annaïck Desmaison, Katia Grenier, Celine Frongia, Corinne Lorenzo, Bernard Ducommun, Valerie Lobjois

Cancer Res (2013) 73 (8_Supplement): 560.

https://doi.org/10.1158/1538-7445.AM2013-560

Published: 15 April 2013

View article titled, Abstract 560: Mechanical stress activates a mitotic checkpoint in multicellular tumor spheroids.

Journal Articles

Abstract 4404: Multicellular tumor spheroid models to evaluate drugs targeting cell cycle checkpoints in 3D.

Bernard Ducommun, Valérie Lobjois, Jennifer Laurent, Céline Frongia, Odile Mondesert, Martine Cazales

Cancer Res (2013) 73 (8_Supplement): 4404.

https://doi.org/10.1158/1538-7445.AM2013-4404

Published: 15 April 2013

View article titled, Abstract 4404: Multicellular tumor spheroid models to evaluate drugs targeting cell cycle checkpoints in 3D.

Journal Articles

Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery

Denis Jullien, Beatrix Bugler, Christine Dozier, Martine Cazales, Bernard Ducommun

Cancer Res (2011) 71 (5): 1968–1977.

https://doi.org/10.1158/0008-5472.CAN-10-2453

Published: 01 March 2011

View article titled, Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery

Includes: Supplementary data

Journal Articles

Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy

Cindy Cavelier, Christine Didier, Naïs Prade, Véronique Mansat-De Mas, Stéphane Manenti, Christian Recher, Cécile Demur, Bernard Ducommun

Cancer Res (2009) 69 (22): 8652–8661.

https://doi.org/10.1158/0008-5472.CAN-09-0939

Published: 11 November 2009

View article titled, Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy

Includes: Supplementary data

Journal Articles

Targeting or exploiting CDC25 phosphatases in cancer therapy?

Bernard Ducommun

Cancer Res (2008) 68 (9_Supplement): SY05-03.

Published: 01 May 2008

View article titled, Targeting or exploiting CDC25 phosphatases in cancer therapy?

Journal Articles

CDC25B Involvement in the Centrosome Duplication Cycle and in Microtubule Nucleation

Rose Boutros, Valérie Lobjois, Bernard Ducommun

Cancer Res (2007) 67 (24): 11557–11564.

https://doi.org/10.1158/0008-5472.CAN-07-2415

Published: 18 December 2007

View article titled, CDC25B Involvement in the Centrosome Duplication Cycle and in Microtubule Nucleation

Includes: Supplementary data

Journal Articles

A novel synthetic CDC25 phosphatase inhibitor inhibits human cancer growth in vitro and in vivo

Gregoire Prevost, Muriel Quaranta, Marie-Cristine Brezak, Celine Frongia, Alban Sidhu, Sophie Chaumeron, Marie-Odile Galcera, Olivier Lavergne, Dennis Bigg, Annie Valette, Philip Kasprzyk, Bernard Ducommun

Cancer Res (2007) 67 (9_Supplement): 3228.

Published: 01 May 2007

View article titled, A novel synthetic CDC25 phosphatase inhibitor inhibits human cancer growth in vitro and in vivo

Journal Articles

Expression level of CDC25B is a key determinant of sensitivity to genotoxic agents.

Bernadette Aressy, Beatrix Bugler, Bernard Ducommun

Cancer Res (2007) 67 (9_Supplement): 4350.

Published: 01 May 2007

View article titled, Expression level of CDC25B is a key determinant of sensitivity to genotoxic agents.

Journal Articles

Study of the regulation of the G2/M checkpoint in acute myeloid leukemia cell lines

Christine Didier, Muriel Quaranta, Cindy Cavelier, Cecile Demur, Stephane Manenti, Bernard Ducommun

Cancer Res (2007) 67 (9_Supplement): 4362.

Published: 01 May 2007

View article titled, Study of the regulation of the G2/M checkpoint in acute myeloid leukemia cell lines

Journal Articles

Cell Adhesion Regulates CDC25A Expression and Proliferation in Acute Myeloid Leukemia

Anne Fernandez-Vidal, Loïc Ysebaert, Christine Didier, Remy Betous, Fabienne De Toni, Naïs Prade-Houdellier, Cécile Demur, Marie-Odile Contour-Galcéra, Grégoire P. Prévost, Bernard Ducommun, Bernard Payrastre, Claire Racaud-Sultan, Stéphane Manenti

Cancer Res (2006) 66 (14): 7128–7135.

https://doi.org/10.1158/0008-5472.CAN-05-2552

Published: 18 July 2006

View article titled, Cell Adhesion Regulates CDC25A Expression and Proliferation in Acute Myeloid Leukemia

Journal Articles

Bypass of a genotoxic-induced G2/M checkpoint in cancer cells is dependent on CDC25B phosphatase expression level

Béatrix Bulger, Muriel Quaranta, Bernadette Aressy, Bernard Ducommun

Cancer Res (2006) 66 (8_Supplement): 753.

Published: 15 April 2006

View article titled, Bypass of a genotoxic-induced G2/M checkpoint in cancer cells is dependent on CDC25B phosphatase expression level

Journal Articles

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases: BN83065

Marie Christine Brezak, Muriel Quaranta, Odile Mondésert, Marie-Odile Galcera, Olivier Lavergne, Philip Kasprzyk, Bernard Ducommun, Gregoire P. Prevost

Cancer Res (2005) 65 (9_Supplement): 154.

Published: 01 May 2005

View article titled, Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases: BN83065

Journal Articles

A Novel Synthetic Inhibitor of CDC25 Phosphatases: BN82002

Marie-Christine Brezak, Muriel Quaranta, Odile Mondésert, Marie-Odile Galcera, Olivier Lavergne, Frédéric Alby, Martine Cazales, Véronique Baldin, Christophe Thurieau, Jeremiath Harnett, Christophe Lanco, Philip G. Kasprzyk, Gregoire P. Prevost, Bernard Ducommun

Cancer Res (2004) 64 (9): 3320–3325.

https://doi.org/10.1158/0008-5472.CAN-03-3984

Published: 03 May 2004

View article titled, A Novel Synthetic Inhibitor of CDC25 Phosphatases: <subtitle>BN82002</subtitle>

NARROW

Abstract 2902: Targeting the tight junction protein claudin-1 in colorectal cancer

Abstract 4023: Gap junctions contribute to anchorage-independent clustering of breast cancer cells

Abstract 5774: Effect of extrinsic and intrinsic solid stress on tumor spheroid growth

Abstract 5053: Tumor cell clustering - Identification of new regulators

Abstract 327: 3D dynamics of the response to cell cycle checkpoint targeting drugs in multicellular tumour spheroids

Cell–Cell Adhesion and Cytoskeleton Tension Oppose Each Other in Regulating Tumor Cell Aggregation

Abstract 2025: Multicellular tumor spheroid 3D models to decipher cancer cell biology and to evaluate anticancer drugs

Abstract 560: Mechanical stress activates a mitotic checkpoint in multicellular tumor spheroids.

Abstract 4404: Multicellular tumor spheroid models to evaluate drugs targeting cell cycle checkpoints in 3D.

Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery

Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy

Targeting or exploiting CDC25 phosphatases in cancer therapy?

CDC25B Involvement in the Centrosome Duplication Cycle and in Microtubule Nucleation

A novel synthetic CDC25 phosphatase inhibitor inhibits human cancer growth in vitro and in vivo

Expression level of CDC25B is a key determinant of sensitivity to genotoxic agents.

Study of the regulation of the G2/M checkpoint in acute myeloid leukemia cell lines

Cell Adhesion Regulates CDC25A Expression and Proliferation in Acute Myeloid Leukemia

Bypass of a genotoxic-induced G2/M checkpoint in cancer cells is dependent on CDC25B phosphatase expression level

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases: BN83065

A Novel Synthetic Inhibitor of CDC25 Phosphatases: BN82002

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only